✦ LIBER ✦

Open prospective trial of 2nd generation anti-HCV (EIA-2) screening of blood donors to prevent posttransfusion hepatitis (PTH)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective efficacy trial of anti-HCV s

✍ González, A; Esteban, JI; Martin-Vega, C; Hernandez, JM; Madoz, P; Mun̄iz, E; To 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 135 KB